HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Alcohol sclerotherapy for benign solitary thyroid nodules].

Abstract
The introduction of new diagnostic methods for the evaluation of solitary thyroid nodules allows for unquestionable differentiation between malignant and benign lesions in most cases. It makes therapeutic procedure other than surgical therapy possible. One of the procedures is the percutaneous alcohol sclerotherapy (PSA). It is the most commonly used for the treatment of thyroid cysts and autonomous thyroid nodules. PSA was first proposed by Livraghi in 1990 as possible therapy for autonomously functioning thyroid nodules. This method is based on the administration of a limited amount of sterile alcohol into the thyroid nodule under direct ultrasonografic control. The application of PSA according to the worked out procedure gives a permanent remission of thyroid cysts in most cases and the 85-100% decrease of thyroid nodule volume. In the case of "toxic" and "pretoxic" type of nodules, a normalization of serum FT3, FT4 and TSH level occurs. Scintigraphy shows recovery of extranodular uptake of radionuclide and effacement of previously hot area of thyroid scintiscan. The following complications were observed after PSA: pain of the injection site, local hematoma, fever, sinus tachycardia, transient dysphonia. The intensity of these complications is generally low.
AuthorsW Zieleźnik, A Sieroń, M Peszel-Barlik, M Zieleźnik, M Simon-Sieroń
JournalWiadomosci lekarskie (Warsaw, Poland : 1960) (Wiad Lek) Vol. 50 Issue 7-9 Pg. 211-6 ( 1997) ISSN: 0043-5147 [Print] Poland
Vernacular TitlePrzezskórna alkoholowa sklerotyzacja łagodnych guzków tarczycy.
PMID9507690 (Publication Type: Journal Article, Review)
Chemical References
  • Ethanol
Topics
  • Administration, Cutaneous
  • Ethanol (administration & dosage)
  • Humans
  • Radionuclide Imaging
  • Remission Induction
  • Sclerotherapy (adverse effects, methods)
  • Thyroid Nodule (diagnostic imaging, therapy)
  • Ultrasonography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: